Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-01

Clinical Trial Update: Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effects of adding chronic oral azithromycin to inhaled tobramycin in people with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • tobramycin (inhaled) (tobramycin)

Snippet

Sponsor: Seattle Children's Hospital | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2021-03-01